Pubmed du 28/03/24
1. Retraction: Blood biomarker discovery for Autism Spectrum Disorder: A proteomic analysis. PLoS One. 2024; 19(3): e0301648.
Ceci une extraction quotidienne des publications sur le TSA à partir de la base de données bibliographique Pubmed.
1. Retraction: Blood biomarker discovery for Autism Spectrum Disorder: A proteomic analysis. PLoS One. 2024; 19(3): e0301648.
1. Correction to: Factors Influencing Music Therapists’ Retention of Clinical Hours with Autistic Clients over Telehealth During the COVID-19 Pandemic.…
1. Abbasi DA, Berry-Kravis E, Zhao X, Cologna SM. Proteomics insights into fragile X syndrome: Unraveling molecular mechanisms and therapeutic…
1. Aydın Ö G, Baykara HB, Akın K, Kahveci S, Şeker G, Güler Y, Öztürk Y. Evaluation of functional gastrointestinal…
1. Abbas A, Fayoud AM, El Din Moawad MH, Hamad AA, Hamouda H, Fouad EA. Safety and efficacy of trofinetide…
1. Abbas A, Fayoud AM, El Din Moawad MH, Hamad AA, Hamouda H, Fouad EA. Safety and efficacy of trofinetide…
1. Online resources for Autism Acceptance Month. Nursing. 2024; 54(4): 63.
1. Emerging signs of autism spectrum disorder in infancy: Putative neural substrate. Dev Med Child Neurol. 2024. RNA and Ribonucleoprotein…
1. Correction: Can we distinguish the consequences of early maltreatment on child behaviour from idiopathic autism?. Arch Dis Child. 2024;…
© 2024 Copyright Centre de Ressources Autisme Rhône-Alpes – CRA Rhône-Alpes - Mentions Légales .